COR

COR

USD

Cencora Inc. Common Stock

$344.530+6.270 (1.854%)

Цена в режиме реального времени

Healthcare
Medical Distribution
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$338.260

Максимум

$347.350

Минимум

$335.905

Объем

2.82M

Фундаментальные показатели компании

Рыночная капитализация

66.8B

Отрасль

Medical Distribution

Страна

United States

Статистические данные торговли

Средний объем

1.44M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $223.92Текущая $344.530Максимум $350.46

Отчет об анализе ИИ

Последнее обновление: 3 нояб. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

Cencora (COR) on a Tear: Riding a Wave of Analyst Upgrades to New Highs

November 03, 2025, 01:45 PM EDT

The Drumbeat of Approval: Analysts Cheer Cencora Forward

The news surrounding Cencora is decidedly upbeat. In the last week of October, two influential firms signaled their confidence in the company's direction. First, UBS maintained its Buy rating and gave its price target a significant boost, moving it from $350 all the way to $380. Just a few days later, Mizuho followed suit, reiterating an Outperform rating and nudging its own target up to $340. This kind of back-to-back positive reinforcement from analysts often catches the market's attention, and it appears to be a key ingredient in the stock's recent performance.

The Anatomy of a Rally: Charting COR's Explosive Climb

Looking at the price chart for the past three months tells a clear story of building momentum. After a choppy August and September that saw the stock trade in a wide range between roughly $273 and $312, October was a different beast entirely. The stock began a powerful and sustained climb, breaking through previous resistance levels. This ascent culminated in a surge to a new 52-week high of $350.46 on October 30th, a move accompanied by a dramatic spike in trading volume. While the stock pulled back slightly to close the month at $337.81, the overall trend is unmistakably upward. This isn't a slow grind; it's an aggressive move higher, suggesting strong conviction from buyers.

Digital Crystal Ball: What the AI Sees for Cencora's Next Move

The algorithmic forecast aligns with the bullish sentiment seen in the news and on the charts. Projections for the immediate future are positive, suggesting the upward momentum could continue. The model anticipates a sequence of gains over the next three trading sessions:

  • Day 1: +1.20%
  • Day 2: +2.23%
  • Day 3: +3.10%

This AI-driven outlook, which is stated to have high confidence, points toward a continuation of the recent trend. It suggests that the slight pullback from the recent peak might be temporary, with more strength potentially on the horizon.

The Bottom Line

Cencora is currently displaying all the signs of a stock with powerful momentum. Positive analyst upgrades appear to be fueling a strong technical breakout, and predictive models expect the run to continue in the very near term. The company's high Return on Equity is a notable fundamental strength.

However, investors should be aware of the risks. The company carries a very high level of debt relative to its equity, a factor that cannot be ignored. Furthermore, the stock just came off a new 52-week high and could be prone to volatility as traders take profits.

For a medium-term investor comfortable with these risks, the data suggests a strategy of engaging with the current trend. A potential entry point could be considered around the $339 level. To manage the risk of a sharp reversal, a stop-loss near $304 seems prudent. If the stock continues its upward trajectory, taking profits around the $344.50 mark could be a reasonable first target.


Disclaimer: This report is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any security. The analysis is based solely on the data provided and may not be comprehensive. Investing in stocks involves risks, including the possible loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Связанные новости

Analyst Upgrades

Mizuho Maintains Outperform on Cencora, Raises Price Target to $340

Mizuho analyst Steven Valiquette maintains Cencora with a Outperform and raises the price target from $334 to $340.

Просмотреть больше
Mizuho Maintains Outperform on Cencora, Raises Price Target to $340
Analyst Upgrades

UBS Maintains Buy on Cencora, Raises Price Target to $380

UBS analyst Kevin Caliendo maintains Cencora with a Buy and raises the price target from $350 to $380.

Просмотреть больше
UBS Maintains Buy on Cencora, Raises Price Target to $380

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 5 нояб. 2025 г., 04:09

МедвежийНейтральныйБычий

66.7% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
Консервативный
Руководство по торговле

Точка входа

$346.14

Взять прибыль

$351.53

Остановить убытки

$310.18

Ключевые факторы

DMI показывает медвежий тренд (ADX:10.6, +DI:4.3, -DI:7.3), что предполагает осторожность
Текущая цена очень близка к уровню поддержки ($345.46), что предполагает сильную возможность покупки
Объем торгов в 12.1 раз превышает среднее значение (11,776), что указывает на чрезвычайно сильное покупательское давление
MACD -0.1665 ниже сигнальной линии -0.0178, что указывает на медвежье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.